Jordan Lane
Member since 2026
I believe that the UK is perfectly placed to drive worldwide scientific advancement and communication and the UKYA is perfectly positioned to lead this.
Bio
Jordan Lane is the Chief Scientific Officer and co-founder of Ignota Labs. He has extensive experience in the AI drug discovery space and is driven by a profound commitment to revolutionizing drug discovery, integrating artificial intelligence with bioscience to enhance drug safety and efficacy. At Ignota Labs, Jordan leads innovation, leveraging his extensive background in biochemistry, genetics, and AI to pioneer transformative treatments in global patient care. His journey began at the University of Nottingham, where he earned a BSc in Biochemistry and Genetics, followed directly by a PhD focused on Alzheimer’s Disease. Jordan’s early academic success included contributing to over 15 works in the field. His work led to strategic roles in the biopharmaceutical industry, from developing oncology assets at AstraZeneca to spearheading AI-driven drug discovery projects at LabGenius and BenevolentAI. His career is marked by a relentless pursuit of excellence, interdisciplinary collaboration, and a visionary approach to the future of medicine.
